These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25750339)

  • 21. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
    Henry LR; Goldberg M; Scott W; Konski A; Meropol NJ; Freedman G; Weiner LM; Watts P; Beard M; McLaughlin S; Cheng JD
    Ann Surg Oncol; 2006 Feb; 13(2):214-20. PubMed ID: 16418887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.
    Sato D; Motegi A; Kadota T; Kojima T; Bando H; Shinmura K; Hori K; Yoda Y; Oono Y; Zenda S; Ikematsu H; Akimoto T; Yano T
    Esophagus; 2020 Jul; 17(3):305-311. PubMed ID: 31965362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
    Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
    Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer.
    Ohnishi K; Ishikawa H; Nakazawa K; Shiozawa T; Mori Y; Nakamura M; Okumura T; Sekine I; Hizawa N; Sakurai H
    Thorac Cancer; 2021 May; 12(9):1320-1327. PubMed ID: 33675285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of proton beam therapy on liver metastases of esophageal cancer: report of a case.
    Muroi H; Nakajima M; Satomura H; Takahashi M; Domeki Y; Murakami M; Nakamura T; Takada A; Kato H
    Int Surg; 2015 Jan; 100(1):180-4. PubMed ID: 25594660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer.
    Chang JH; Lee NK; Kim JY; Kim YJ; Moon SH; Kim TH; Kim JY; Kim DY; Cho KH; Shin KH
    Radiother Oncol; 2013 Aug; 108(2):209-14. PubMed ID: 23891102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
    Park JW; Kim JH; Choi EK; Lee SW; Yoon SM; Song SY; Lee YS; Kim SB; Park SI; Ahn SD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):691-7. PubMed ID: 20888705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma.
    Adelstein DJ; Rice TW; Tefft M; Koka A; Van Kirk MA; Kirby TJ; Taylor ME
    Cancer; 1994 Sep; 74(6):1680-5. PubMed ID: 8082068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.
    Hoppe BS; Flampouri S; Henderson RH; Pham D; Bajwa AA; D'Agostino H; Huh SN; Li Z; Mendenhall NP; Nichols RC
    Clin Lung Cancer; 2012 Sep; 13(5):352-8. PubMed ID: 22264659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsurgical management of esophageal adenocarcinoma.
    Gujral DM; Hawkins MA; Leonulli BG; Ashley S; Chau I; Cunningham D; Tait D
    Clin Colorectal Cancer; 2011 Sep; 10(3):165-70. PubMed ID: 21855037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].
    Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.